RPRX
Royalty Pharma Plc
NASDAQ · Healthcare · Biotechnology · US
$65.93
+1.71%0
Insider buys (3m)
7
Insider sells (3m)
-$13.0M
Net value (3m)
+11.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 5, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 4,126 | $57 |
| Sep 30, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 4,126 | $58 |
| Sep 30, 2026 | Bassler Bonnie L · director | A-Award | 642 | $58 |
| Sep 24, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 3,927 | $59 |
| Sep 24, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 96,073 | $59 |
| Aug 19, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 100,000 | $60 |
| Aug 17, 2026 | Coyne Terrance P. · officer: EVP & CFO | Sale | 1,772 | $59 |
| Aug 17, 2026 | Coyne Terrance P. · officer: EVP & CFO | Sale | 9,230 | $59 |
| Aug 7, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | A-Award | 11,002 | $0.00 |
| Aug 7, 2026 | Coyne Terrance P. · officer: EVP & CFO | A-Award | 11,002 | $0.00 |
| Aug 7, 2026 | Legorreta Pablo G. · director, officer: CEO, Chairman of the Board | A-Award | 65,216 | $0.00 |
| Aug 7, 2026 | Urist Marshall · officer: EVP, Research & Investments | A-Award | 8,252 | $0.00 |
| Jul 2, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 9,099 | $56 |
| Jun 30, 2026 | Bassler Bonnie L · director | A-Award | 689 | $54 |
| Jun 25, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 32,408 | $54 |
| Jun 25, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 117,592 | $54 |
| Jun 25, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 9,098 | $55 |
| Jun 8, 2026 | Ho Carole · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | WEATHERMAN ELIZABETH H · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | HODGSON DAVID C · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Coric Vlad · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Norden Gregory · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Bassler Bonnie L · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Engelbert Catherine M. · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | LOVE TED W · director | A-Award | 4,545 | $0.00 |
| May 28, 2026 | Coyne Terrance P. · officer: EVP & CFO | Sale | 64,399 | $54 |
| May 21, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 13,684 | $53 |
| May 15, 2026 | Norden Gregory · director | Sale | 3,045 | $53 |
| May 15, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 13,684 | $53 |
| May 8, 2026 | Legorreta Pablo G. · director, officer: CEO, Chairman of the Board | A-Award | 143,821 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 247Increased 527Reduced 380Sold out 53
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MORGAN STANLEY | Reduced | 43,571,633 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 42,931,597 | Aug 13, 2026 |
| Capital International Investors | Increased | 35,273,770 | Aug 12, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Increased | 35,005,736 | May 13, 2026 |
| BlackRock, Inc. | Increased | 27,832,977 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 25,907,745 | May 13, 2026 |
| FMR LLC | Reduced | 25,152,242 | May 15, 2026 |
| FMR LLC | Reduced | 24,513,814 | Aug 13, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 16,155,677 | May 8, 2026 |
| STATE STREET CORP | Increased | 12,338,229 | Sep 22, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 11,193,657 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 10,989,851 | May 15, 2026 |
| Swedbank AB | Reduced | 10,726,608 | Jul 15, 2026 |
| Swedbank AB | Reduced | 10,260,593 | Oct 27, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 10,015,578 | Aug 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 5, 2026